Search results
Results from the WOW.Com Content Network
Tetracaine, also known as amethocaine, is an ester local anesthetic used to numb the eyes, nose, or throat. [2] It may also be applied to the skin before starting intravenous therapy to decrease pain from the procedure. [3] Typically it is applied as a liquid to the area. [2]
Inferior alveolar nerve block (abbreviated to IANB, and also termed inferior alveolar nerve anesthesia or inferior dental block) is a nerve block technique which induces anesthesia (numbness) in the areas of the mouth and face innervated by one of the inferior alveolar nerves which are paired on the left and right side.
The U.S. Veterans Affairs and Department of Defense 2015 guidelines on substance use disorders list topiramate as a "strong for" in its recommendations for alcohol use disorder. [ 30 ] Other uses include treatment of obesity, [ 31 ] [ 32 ] binge eating disorder , [ 33 ] and off-setting weight gain induced by taking antipsychotic medications.
The rate of systemic absorption of bupivacaine and other local anesthetics is dependent upon the dose and concentration of drug administered, the route of administration, the vascularity of the administration site, and the presence or absence of epinephrine in the preparation. [29] Onset of action (route and dose-dependent): 1–17 min
Examples of these factors include the patients individual response to the drug, vascularity and pH of tissues at the site of drug administration, the type of injection administered etc. [3] Hence figures citing the duration of action of local anaesthetics is an approximation, as extreme variations may occur among patients.
Hypoesthesia or numbness is a common side effect of various medical conditions that manifests as a reduced sense of touch or sensation, or a partial loss of sensitivity to sensory stimuli. In everyday speech this is generally referred to as numbness.
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.
Tardive dyskinesia (TD) is an iatrogenic disorder that results in involuntary repetitive body movements, which may include grimacing, sticking out the tongue or smacking the lips, [1] which occurs following treatment with medication. [6] [7] Additional motor symptoms include chorea or athetosis. [1]